Search

everythinglearnresearchcommunity

for

Search:↓

Skin problems are common in lupus patients and should be treated early to prevent worsening.

Some patients with mycosis fungoides or Sézary syndrome experience hair loss, which may be similar to alopecia areata or linked to skin lesions, possibly due to abnormal T cells, and bexarotene can help treat it.

The document concludes that using gadolinium-based contrast agents during MRI can be linked to Nephrogenic Systemic Fibrosis in patients with severe kidney disease.

Trichoscopy helps accurately diagnose Netherton syndrome, often mistaken for atopic dermatitis.

Skin reactions to antidepressants are common but usually not serious and can be treated.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

Doctors should use a detailed patient history and physical exam to diagnose joint pain, and consult a rheumatologist early for suspected autoimmune diseases.

Some COVID-19 patients have different skin problems, which might be the only sign of the virus or related to other health issues.

Chemotherapy often causes hair loss, nail changes, and mouth issues, but these are usually manageable.

Modulating Cytochrome P450 activity could help develop new skin disease treatments.

The review emphasizes the need to recognize skin conditions that affect hair follicles and sweat glands to avoid misdiagnosis.

Rosacea is a skin condition with unclear causes, classified into four subtypes.

Obesity affects skin health, causing conditions like acanthosis nigricans and may require different treatment approaches.

Skin problems are very common in people with end-stage kidney disease.

Thyroid diseases may contribute to autoimmune skin diseases, and more research is needed on their relationship.

Hair loss is common in autoimmune diseases and can be an early sign of the condition, often requiring prompt treatment to prevent permanent damage.

Ezh2 controls skin development by balancing signals for dermal and epidermal growth.

New melanoma treatments can cause skin side effects, including skin cancer and rashes, but combining treatments may reduce these risks.

Skin problems are common in Bangladesh due to arsenic, prompt treatment of diabetic foot ulcers is crucial, maternal transmission causes most neonatal herpes, treatments for pediatric vasculitis are effective, the chickenpox vaccine works, more frequent UVB therapy helps psoriasis, certain jobs increase hand dermatitis risk, monoclonal antibodies treat psoriasis well, lifestyle affects psoriasis, alefacept improves psoriasis, imiquimod cream partially clears basal cell carcinoma, and iron may not help chronic hair loss.

Sleep problems and skin issues affect each other; poor sleep can worsen skin conditions, and some skin treatments can improve or harm sleep quality.

The osteopontin gene is active in a specific part of rat hair follicles during a certain hair growth phase and might affect hair cycle and diseases.

The document concludes that skin aging in women can be caused by UV exposure and hormonal changes, and treatments like hormone replacement therapy and various skin therapies can help.

Chronic kidney disease can cause skin problems that affect patient quality of life, and treating these conditions can improve outcomes.

Skin changes like hair loss, white patches, and nail changes are common in children after bone marrow transplants, often linked to chronic rejection.

Skin changes can indicate hormonal imbalances and help diagnose endocrine disorders.

The study concluded that tick infestation was the most common skin problem in hospitalized dogs in Chennai, with various treatments used for different conditions.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Ayurveda offers a safer and effective way to manage Seborrheic dermatitis without severe side effects.

Niosomes are a promising and effective way to deliver drugs through the skin.

Infliximab improved skin and bowel symptoms in Crohn's disease but caused side effects and the disease returned after stopping treatment.